Literature DB >> 10820287

Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts.

Y Watarai1, S Koga, D R Paolone, T M Engeman, C Tannenbaum, T A Hamilton, R L Fairchild.   

Abstract

Chemokines direct leukocyte recruitment into sites of tissue inflammation and may facilitate recruitment of leukocytes into allografts following transplantation. Although the expression of chemokines during rejection of MHC-disparate allografts has been examined, chemokine expression in MHC-matched/multiple minor histocompatibility Ag-disparate allografts has not been tested. The intraallograft RNA expression of several C-X-C and C-C chemokines was tested during rejection of full thickness skin grafts from B10. D2 donors on control Ig-, anti-CD4 mAb-, and anti-CD8 mAb-treated BALB/c recipients. In all recipients, two patterns of intragraft chemokine expression were observed during rejection of these grafts: 1) macrophage-inflammatory protein-1alpha, macrophage-inflammatory protein-1beta, GRO-alpha (KC), JE, and IFN-gamma-inducible protein (IP-10) were expressed at equivalent levels in allo- and isografts for 2-4 days posttransplant and then returned to low or undetectable levels; and 2) IP-10 and monokine induced by IFN-gamma (Mig) were expressed in the allografts 3 days before rejection was completed, suggesting a possible role in recruiting primed T cells into the allograft. Three days before completion of rejection, intraallograft IP-10 protein was restricted to the epidermis, whereas Mig was located in the lower dermis and associated with the intense infiltration of mononuclear cells. Treatment of B10.D2 recipients with rabbit antiserum to Mig, but not to IP-10, delayed rejection of the allografts 3-4 days. The results suggest that Mig mediates optimal recruitment of T cells into MHC-matched/multiple minor histocompatibility Ag-disparate allografts during rejection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820287     DOI: 10.4049/jimmunol.164.11.6027

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Allopeptides and the alloimmune response.

Authors:  Ankit Bharat; T Mohanakumar
Journal:  Cell Immunol       Date:  2007-07       Impact factor: 4.868

Review 2.  Overcoming hurdles in developing successful drugs targeting chemokine receptors.

Authors:  Thomas J Schall; Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2011-04-15       Impact factor: 53.106

3.  Isolation of scFv fragments specific for monokine induced by interferon-gamma (MIG) using phage display.

Authors:  Edward Eteshola
Journal:  J Immunol Methods       Date:  2010-04-09       Impact factor: 2.303

4.  Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury.

Authors:  M Miura; X Fu; Q W Zhang; D G Remick; R L Fairchild
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 5.  Manipulating the type 1 vs type 2 balance in type 1 diabetes.

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

6.  Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.

Authors:  Michael B Auerbach; Naohiko Shimoda; Hiroyuki Amano; Joshua M Rosenblum; Danielle D Kish; Joshua M Farber; Robert L Fairchild
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

7.  CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.

Authors:  T Nozaki; J M Rosenblum; A D Schenk; D Ishii; R L Fairchild
Journal:  Am J Transplant       Date:  2009-07-28       Impact factor: 8.086

8.  The effect of skin allografting on the equine endometrial cup reaction.

Authors:  A P Adams; J G Oriol; R E Campbell; Y C Oppenheim; W R Allen; D F Antczak
Journal:  Theriogenology       Date:  2007-06-07       Impact factor: 2.740

Review 9.  Regulation of chemokine expression by antiinflammatory cytokines.

Authors:  Thomas A Hamilton; Yoshihiro Ohmori; Julie Tebo
Journal:  Immunol Res       Date:  2002       Impact factor: 4.505

10.  CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells.

Authors:  Ye Feng; Donghua Wang; Rongwen Yuan; Christina M Parker; Donna L Farber; Gregg A Hadley
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.